Table 3.
Inhibition of bioluminescence (I%) of A. fischeri after 15 and 30′ of exposure to 90% of maximum concentration samples (100 mg/L). The assay was performed at 15° ± 1 °C. Marine protocol EC50 Zn2+ = 10.26 mg/L (C.L. 95% = 9.22–11.43); Freshwater protocol EC50 Zn2+ = 1.04 mg/L (C.L. 95% = 0.80–1.36)
| Samples | Bioluminescence inhibition at max concentration | |||||||
|---|---|---|---|---|---|---|---|---|
| Marine protocol | Freshwater protocol | |||||||
| Mean I% (15′) | S.D | Mean I% (30′) | S.D | Mean I% (15′) | S.D | Mean I% (30′) | S.D | |
| betaine:ethylene glycol | 6.16 | 0.32 | 4.80 | 0.62 | − 22.24 | 0.13 | − 15.72 | 1.56 |
| betaine:citric acid | 7.08 | 1.69 | 7.79 | 2.54 | − 8.59 | 0.85 | − 14.01 | 0.91 |
| betaine:glycerol | 3.79 | 0.92 | 4.33 | 0.17 | − 10.19 | 3.97 | − 13.95 | 0.09 |
| betaine:levulinic acid | 4.68 | 1.91 | 3.82 | 1.20 | − 12.82 | 1.80 | − 14.93 | 0.21 |
| betaine:L-lactic acid | 0.03 | 1.11 | 0.51 | 0.53 | − 13.84 | 3.82 | − 19.12 | 6.02 |
| proline:glycerol | 2.76 | 1.91 | 2.89 | 2.17 | − 11.57 | 4.68 | − 16.76 | 7.08 |
| proline:lactic acid | − 0.26 | 0.89 | − 1.09 | 0.51 | − 14.53 | 1.65 | − 17.38 | 0.62 |
| proline:levulinic acid | 3.78 | 2.42 | 3.43 | 0.02 | − 7.97 | 2.80 | − 14.58 | 2.00 |
| proline:malic acid | 11.15 | 1.26 | 23.45 | 0.84 | − 5.28 | 2.97 | − 6.82 | 2.18 |
| cholinium bitartrate:citric acid | 6.41 | 1.81 | 10.51 | 0.71 | − 14.71 | 2.84 | − 17.17 | 4.84 |
| choline acetate:imidazole | 4.21 | 1.43 | 5.51 | 0.09 | − 13.25 | 0.52 | − 14.26 | 1.56 |
| choline acetate:levulinic acid | 6.89 | 0.17 | 9.79 | 0.83 | − 10.42 | 0.40 | − 13.87 | 0.08 |
| choline acetate:glycolic acid | 1.20 | 2.25 | 4.65 | 0.95 | − 10.87 | 1.04 | − 15.25 | 1.31 |
| choline acetate:diglycolic acid | 2.80 | 0.52 | 3.38 | 0.32 | − 15.43 | 1.56 | − 17.94 | 1.47 |
| choline acetate:citric acid | 5.95 | 2.44 | 11.77 | 0.43 | − 11.03 | 0.54 | − 14.61 | 0.33 |